Kapil M. Khambholja


Also Known As
Vice President and Head of Medical Writing and RWE, Genpro Research Inc

Detail and Goal Oriented researcher with extensive clinical research and drug development experience with business acumen. Able to achieve high impact results with assertive & positive attitude. Passionate about strategy, evolving regulations and Innovation eventually leading to a positive impact on patient's lives. Having worked with leading global pharma companies and also service industry, I look forward to my entrepreneurial journey where we aim to bridge the gaps using innovative customised solutions and technology that enable faster and safer clinical development. Specialties: + Medical and scientific writing, + Drug safety (Aggregate reporting, Risk Management Plans), + Client-vendor strategic partnerships, + Business strategy & operations. + Extensive knowledge of regulations (USFDA, EMA, MHRA) and overall Drug Discovery & Development. Therapeutic area contributions: Immunology, Rheumatology, Oncology, Virology, Cardiovascuar & Metabolism, Neuro, Transplantation (Heart, liver, kidney) and advanced therapeutics CAR-T, gene and microbiome... https://www.bloomberg.com/press-releases/2021-03-18/cps-health-care-and-telewellness-present-the-rating-of-covid-technologies-on-a-lifetime-award

Voted (0)

Works (0)

Video (0)

News about Kapil M. Khambholja(0)

Join our Telegram Channel!